NYSE ARCA | ETF
The fund invests primarily in equity securities, principally common and preferred stocks of companies of any market capitalization.
Under normal market conditions, the fund invests at least 80% of its net assets, plus borrowings for investment purposes, in securities of companies principally engaged in the research, development, production, or distribution of products and services related to the health care industry ("health care companies").
It is non-diversified.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
ASND | Ascendis Pharma AS | Healthcare | Biotechnology | 18.27% |
LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 12.98% |
UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 9.10% |
LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 6.66% |
DXCM | DexCom Inc | Healthcare | Medical Devices | 4.20% |
ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 3.76% |
SNY | Sanofi ADR | Healthcare | Drug Manufacturers - General | 3.55% |
LNTH | Lantheus Holdings Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.87% |
HUM | Humana Inc | Healthcare | Healthcare Plans | 2.87% |
MASI | Masimo Corporation | Healthcare | Medical Devices | 2.85% |
OPCH | Option Care Health Inc | Healthcare | Medical Care Facilities | 2.43% |
GKOS | Glaukos Corp | Healthcare | Medical Devices | 2.41% |
6XC | SOLENO THERAPEUT. DL-001 | Healthcare | Biotechnology | 2.38% |
CVS | CVS Health Corp | Healthcare | Healthcare Plans | 2.32% |
ICLR | ICON PLC | Healthcare | Diagnostics & Research | 2.26% |
VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.25% |
PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 2.16% |
PODD | Insulet Corporation | Healthcare | Medical Devices | 2.05% |
NTRA | Natera Inc | Healthcare | Diagnostics & Research | 1.88% |
PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 1.83% |